This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting the central nervous system (CNS), including potential treatments for neurological disorders such as Parkinson’s disease and schizophrenia. Its chiral structure makes it valuable in the design of enantiomerically pure compounds, which are critical for enhancing drug efficacy and reducing side effects. Additionally, it is explored in the development of receptor-specific ligands, aiding in the study of biochemical pathways and drug-receptor interactions.